Billion. Merck announced it is snapping up Sigma Aldrich and a 17 billion deal. 7. 6 billion dollar acquisition. Hans mercks deal helps it move away from developing pharmaceuticals why is that important . This is a Company Switching midstream. I havent had a new drug approved since 2003, and merck is moving away from being a pharmaceutical company. Of theirl get 60 revenues from the pharmaceutical side but theyre moving more toward chemicals and plastic. That is what they get with sigmaaldrich. They make many of the chemicals that go into testing and drugs, they get a big footprint in the u. S. As well. The stock sits at a hundred 40 per share and it closed on friday at 100. That seems like a 40 rhenium. Premium. In to thes this fit overall strategy . Becomings is clearly an industrial giant and wants to be an oilproducing servicing company. They have been eyeing dresser errand for some time. I know you have reported extensively on it, it is a veritable revolution. You have a German Co